Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04560166
Title Naxitamab and GM-CSF in Combination With IT in Patients With High-Risk Neuroblastoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Y-mAbs Therapeutics
Indications
Therapies
Age Groups: adult | senior | child
Covered Countries


No variant requirements are available.